Predicate |
Object |
contentType |
Journal Article |
endingPage |
111 |
issn |
2005-7563 2005-6419 |
issueIdentifier |
2 |
pageRange |
109-111 |
publicationName |
Korean Journal of Anesthesiology |
startingPage |
109 |
bibliographicCitation |
Jung KT. Do we need to adjust the effect-site concentration of propofol in patients undergoing chemotherapy? Korean J Anesthesiol. 2022 Apr;75(2):109–11. PMID: 35378573; PMCID: PMC8980287. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2486-9961 |
date |
2022-04-01^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.4097/kja.22098 https://pubmed.ncbi.nlm.nih.gov/PMC8980287 https://pubmed.ncbi.nlm.nih.gov/35378573 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37602 https://portal.issn.org/resource/ISSN/2005-7563 https://portal.issn.org/resource/ISSN/2005-6419 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Do we need to adjust the effect-site concentration of propofol in patients undergoing chemotherapy? |
discusses |
http://id.nlm.nih.gov/mesh/M0027999 http://id.nlm.nih.gov/mesh/M0024130 http://id.nlm.nih.gov/mesh/M0010885 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D015742 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D018686 http://id.nlm.nih.gov/mesh/D006993 http://id.nlm.nih.gov/mesh/D006801 |